title: Five years' experience with quadruple sequential immunosuppression.
authors.affiliation: Service de Pédiatrie 1, Hôpital de Hautepierre, Strasbourg, France.
authors.forename: M
authors.initials: M
authors.lastname: Fischbach
authors.forename: P
authors.initials: P
authors.lastname: Wolff
authors.forename: M M
authors.initials: MM
authors.lastname: Tongio
authors.forename: K
authors.initials: K
authors.lastname: Boudjema
authors.forename: D
authors.initials: D
authors.lastname: Christmann
authors.forename: A
authors.initials: A
authors.lastname: Steib
authors.forename: P
authors.initials: P
authors.lastname: Sauvage
authors.forename: P
authors.initials: P
authors.lastname: Desprez
authors.forename: L
authors.initials: L
authors.lastname: Mengus
authors.forename: U
authors.initials: U
authors.lastname: Simeoni
mesh_terms: D000293:Adolescent; D000961:Antilymphocyte Serum / Q000008:administration & dosage; D001379:Azathioprine / Q000008:administration & dosage; D002648:Child; D002675:Child, Preschool; D016572:Cyclosporine / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D006084:Graft Rejection / Q000517:prevention & control; D006085:Graft Survival / Q000276:immunology / Q000502:physiology; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods*; D007223:Infant; D016030:Kidney Transplantation / Q000276:immunology* / Q000379:methods* / Q000502:physiology; D011239:Prednisolone / Q000008:administration & dosage; D011241:Prednisone / Q000008:administration & dosage; D011446:Prospective Studies
chemical_list: D000961:Antilymphocyte Serum; D016572:Cyclosporine; D011239:Prednisolone; D001379:Azathioprine; D011241:Prednisone